Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Ribonucleotide excision repair is crucial to prevent skin cancer.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

EGFR helps protect hair follicles from bacterial infections.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Nilotinib can cause skin issues like red bumps and hair loss.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.